Pan Du

9.7k total citations · 4 hit papers
62 papers, 6.0k citations indexed

About

Pan Du is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pan Du has authored 62 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pan Du's work include Cancer Genomics and Diagnostics (19 papers), Gene expression and cancer classification (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Pan Du is often cited by papers focused on Cancer Genomics and Diagnostics (19 papers), Gene expression and cancer classification (8 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Pan Du collaborates with scholars based in United States, China and Australia. Pan Du's co-authors include Warren A. Kibbe, Simon Lin, Simon Lin, Nadereh Jafari, Lifang Hou, Chiang‐Ching Huang, Xiao Zhang, Wolfgang Huber, Guanglei Zhuang and Ho-June Lee and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Pan Du

56 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

lumi: a pipeline for processing Illumina microarray

2008 1.6k citations Pan Du, Warren A. Kibbe et al. Bioinformatics profile →
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

2010 1.4k citations Pan Du, Chiang‐Ching Huang et al. profile →
Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching

2006 547 citations Pan Du, Warren A. Kibbe et al. Bioinformatics profile →
Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells

2014 438 citations Ho-June Lee, Guanglei Zhuang et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pan Du United States	28	3.7k	991	838	820	730	62	6.0k
Chiang‐Ching Huang United States	32	3.5k 1.0×	1.2k 1.2×	653 0.8×	698 0.9×	1.1k 1.6×	91	6.2k
Mario Medvedovic United States	48	3.8k 1.0×	1.4k 1.4×	629 0.8×	779 0.9×	570 0.8×	162	6.9k
Marina Sirota United States	37	4.2k 1.1×	1.1k 1.1×	1.3k 1.6×	787 1.0×	693 0.9×	141	7.9k
George C. Tseng United States	52	4.1k 1.1×	1.4k 1.4×	796 0.9×	812 1.0×	768 1.1×	214	8.7k
Warren A. Kibbe United States	29	6.3k 1.7×	1.4k 1.4×	1.5k 1.8×	689 0.8×	608 0.8×	71	9.5k
Brooke L. Fridley United States	37	2.6k 0.7×	1.0k 1.0×	1.0k 1.2×	1.1k 1.3×	451 0.6×	221	5.1k
Fred A. Wright United States	50	3.7k 1.0×	954 1.0×	1.8k 2.1×	767 0.9×	836 1.1×	195	8.2k
Sara Mostafavi Canada	30	5.3k 1.4×	1.1k 1.1×	1.4k 1.7×	608 0.7×	722 1.0×	82	8.1k
Gregory W. Gundersen United States	10	4.7k 1.3×	1.3k 1.3×	744 0.9×	801 1.0×	701 1.0×	11	7.6k
Maureen A. Sartor United States	49	5.1k 1.4×	1.4k 1.4×	895 1.1×	828 1.0×	542 0.7×	169	8.6k

Countries citing papers authored by Pan Du

Since Specialization

Citations

This map shows the geographic impact of Pan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Du more than expected).

Fields of papers citing papers by Pan Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Du. The network helps show where Pan Du may publish in the future.

Co-authorship network of co-authors of Pan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Pan Du. A scholar is included among the top collaborators of Pan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan Du. Pan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Rong, et al.. (2025). Global burden and trends in ovarian cancer attributable to environmental risks and occupational risks in females aged 20–49 from 1990 to 2021, with projections to 2050: a cross-sectional study. BMC Public Health. 25(1). 2547–2547.

Tan, Alan, Giancarlo Bonora, Binggang Xiang, et al.. (2025). Comprehensive bladder cancer molecular profiling and monitoring based on mutational, epigenomic, and expression data from real-world patients.. Journal of Clinical Oncology. 43(5_suppl). 860–860.

Li, Xingjiang, et al.. (2024). Analysis of metabolic differences between Jiaosu fermented from dendrobium flowers and stems based on untargeted metabolomics. Heliyon. 10(5). e27061–e27061. 3 indexed citations

Zhang, Ruiyun, Di Jin, Guangyu Wu, et al.. (2023). Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer. Clinical Cancer Research. 29(20). 4040–4046. 18 indexed citations

Fettke, Heidi, Chao Dai, Edmond M. Kwan, et al.. (2023). BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. EBioMedicine. 95. 104738–104738. 21 indexed citations

Zheng, Tiantian, Xiaoran Liu, Bin Shao, et al.. (2022). Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of Translational Medicine. 20(1). 211–211. 12 indexed citations

Liu, Xiaoran, Andrew A. Davis, Feng Xie, et al.. (2021). Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China. Breast Cancer Research and Treatment. 190(2). 213–226. 5 indexed citations

Zhang, Ruiyun, Feng Xie, Yue Zhang, et al.. (2021). Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer. The Journal of Urology. 206(4). 873–884. 36 indexed citations

Hauser, Christine, Patricia Bukczynska, Nicole Ng, et al.. (2021). Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer. Asia-Pacific Journal of Clinical Oncology. 17. 1 indexed citations

10.

Kohli, Manish, Winston Tan, Tiantian Zheng, et al.. (2020). Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer. EBioMedicine. 54. 102728–102728. 89 indexed citations

11.

Lee, Ho-June, Guanglei Zhuang, Yi Cao, et al.. (2014). Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells. Cancer Cell. 26(2). 207–221. 438 indexed citations breakdown →

12.

Shames, David S., Kristi Elkins, Kimberly Walter, et al.. (2013). Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. Clinical Cancer Research. 19(24). 6912–6923. 59 indexed citations

13.

Kim, Walter, Thomas Holcomb, Tom Januario, et al.. (2012). DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non–Small Cell Lung Cancer. Clinical Cancer Research. 18(8). 2360–2373. 66 indexed citations

14.

Zhang, Xiao, Andrew D. Wallace, Pan Du, et al.. (2012). DNA methylation alterations in response to pesticide exposure in vitro. Environmental and Molecular Mutagenesis. 53(7). 542–549. 67 indexed citations

15.

Du, Pan, et al.. (2011). Gene Expression Changes in Retinal Müller (Glial) Cells Exposed to Elevated Pressure. Current Eye Research. 36(8). 754–767. 6 indexed citations

16.

Huang, Chiang‐Ching, Kiang Liu, Richard M. Pope, et al.. (2011). Activated TLR Signaling in Atherosclerosis among Women with Lower Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis. PLoS ONE. 6(6). e21067–e21067. 20 indexed citations

17.

Lin, Simon, Pan Du, Nadereh Jafari, & Toru Ouchi. (2009). Using Free and Open-Source Bioconductor Packages to Analyze Array Comparative Genomics Hybridization (aCGH) Data. Current Genomics. 10(1). 60–63. 2 indexed citations

18.

Wang, Haihui, Yi‐Jun Chang, & Pan Du. (2008). Application of Framelet Transform to the MS-based Proteomics Data Preprocessing.. 379–382. 1 indexed citations

19.

Miao, Haixi, Lin Chen, Sean M. Riordan, et al.. (2008). Gene Expression and Functional Studies of the Optic Nerve Head Astrocyte Transcriptome from Normal African Americans and Caucasian Americans Donors. PLoS ONE. 3(8). e2847–e2847. 19 indexed citations

20.

Du, Pan, Warren A. Kibbe, & Simon Lin. (2008). lumi: a pipeline for processing Illumina microarray. Bioinformatics. 24(13). 1547–1548. 1622 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact